202 related articles for article (PubMed ID: 25669993)
1. Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy.
Beppu M; Sawai S; Misawa S; Sogawa K; Mori M; Ishige T; Satoh M; Nomura F; Kuwabara S
J Neuroimmunol; 2015 Feb; 279():7-10. PubMed ID: 25669993
[TBL] [Abstract][Full Text] [Related]
2. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
3. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
4. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
5. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
7. Increased IP-10 production by blood-nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy.
Shimizu F; Oishi M; Sawai S; Beppu M; Misawa S; Matsui N; Miyashiro A; Maeda T; Takeshita Y; Nishihara H; Sano Y; Sato R; Kaji R; Kuwabara S; Kanda T
J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):444-450. PubMed ID: 30523038
[TBL] [Abstract][Full Text] [Related]
8. Increased Levels of IL-34 in Acquired Immune-Mediated Neuropathies.
Rezaei S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
J Mol Neurosci; 2021 Jan; 71(1):137-141. PubMed ID: 32588399
[TBL] [Abstract][Full Text] [Related]
9. Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF.
Mei FJ; Ishizu T; Murai H; Osoegawa M; Minohara M; Zhang KN; Kira J
J Neurol Sci; 2005 Jan; 228(1):75-85. PubMed ID: 15607214
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Nennesmo I; Kouwenhoven M; Huang YM; Link H; Pashenkov M
J Neuroimmunol; 2005 Feb; 159(1-2):165-76. PubMed ID: 15652416
[TBL] [Abstract][Full Text] [Related]
11. Different distribution of demyelination in chronic inflammatory demyelinating polyneuropathy subtypes.
Shibuya K; Tsuneyama A; Misawa S; Sekiguchi Y; Beppu M; Suichi T; Suzuki YI; Nakamura K; Kano H; Kuwabara S
J Neuroimmunol; 2020 Apr; 341():577170. PubMed ID: 32006783
[TBL] [Abstract][Full Text] [Related]
12. High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy.
Sangsefidi S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
J Mol Neurosci; 2020 Dec; 70(12):1997-2000. PubMed ID: 32472395
[TBL] [Abstract][Full Text] [Related]
13. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
Dionne A; Nicolle MW; Hahn AF
Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
[TBL] [Abstract][Full Text] [Related]
14. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy.
Chang CW; Wu HC; Lyu RK; Lo YS; Chen CM; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Weng YC; Wei PT; Lo AL; Chang KH
Clin Chim Acta; 2018 Jan; 476():49-53. PubMed ID: 29137897
[TBL] [Abstract][Full Text] [Related]
16. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
[TBL] [Abstract][Full Text] [Related]
17. Bochum ultrasound score allows distinction of chronic inflammatory from multifocal acquired demyelinating polyneuropathies.
Kerasnoudis A; Pitarokoili K; Gold R; Yoon MS
J Neurol Sci; 2015 Jan; 348(1-2):211-5. PubMed ID: 25534358
[TBL] [Abstract][Full Text] [Related]
18. Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S; Misawa S
Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and long-term characteristics of the subtypes of chronic inflammatory demyelinating polyneuropathy].
Shimizu F; Nemoto J; Takeshita Y; Maeda T; Koga M; Kanda T
Rinsho Shinkeigaku; 2022 Mar; 62(3):173-177. PubMed ID: 35228460
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
